A Double-Blind Trial of Budesonide Ointment and Betamethasone-17-Valerate Ointment in Psoriasis
- 1 May 1981
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 9 (3) , 236-238
- https://doi.org/10.1177/030006058100900316
Abstract
In a double-blind within-patient clinical trial in psoriasis, budesonide 0.025% ointment has been shown to be at least as efficient as betamethasone 17-valerate 0.1% ointment. A lower concentration of budesonide ointment, 0.01%, was used for 4 weeks of maintenance treatment. This concentration controlled residual symptoms well in a majority of the patients, thirty-two in number.This publication has 3 references indexed in Scilit:
- Clinical trial of a potent non-halogenated topical steroid, BudesonideActa Dermato-Venereologica, 1981
- The clinical assessment of topical corticosteroid activityBritish Journal of Dermatology, 1976